{
  "main_header": {
    "sid": 1002885,
    "name": "Aspira Pathlab",
    "stock_name": "Aspira Pathlab",
    "full_name": "Aspira Pathlab & Diagnostics Ltd",
    "name_url": "stocks-analysis/aspira-pathlab",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "68.00",
    "chg": 2.06,
    "chgp": "3.12%",
    "dir": 1,
    "prev_price": "65.94",
    "mcapval": "68.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 540788,
    "symbol": "",
    "ind_name": "Hospital & Healthcare Services",
    "ind_code": 94,
    "isin": "INE500C01017",
    "curr_date": "Apr 11, 12:49 PM",
    "curr_time": "22:27 PM",
    "bse_nse_vol": 1715,
    "exc_status": "Active",
    "traded_date": "Apr 11, 2025",
    "traded_date_str": "2025 04 11",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://sandbox-www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/aspira-pathlab-1002885-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Aspira Pathlab Faces Intense Selling Pressure Amid Significant Price Declines",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/aspira-pathlab-diagnostics-ltd-faces-selling-pressure-with-4-99-decline-amid-ongoing-losses-1693620",
        "imagepath": "",
        "date": "2025-04-03 09:35:24",
        "description": "Aspira Pathlab & Diagnostics Ltd is currently facing significant selling pressure, with the stock showing only sellers today. The stock has experienced a notable decline of 4.99% in just one day, significantly underperforming the Sensex, which fell by only 0.58%. Over the past week, Aspira has seen a staggering loss of 18.53%, while the Sensex declined by 1.85%. \n\nThis trend of consecutive losses extends to seven days, during which Aspira has plummeted by 28.13%. The stock opened today at Rs 73.09, reflecting a gap down, and reached an intraday low of the same price, indicating a lack of upward movement. \n\nIn terms of performance metrics, Aspira's one-month performance shows a decline of 4.64%, contrasting sharply with the Sensex's gain of 4.22%. Despite a strong one-year performance of 115.86% compared to the Sensex's 3.11%, the recent downturn raises questions about potential contributing factors to the s..."
      },
      {
        "title": "Aspira Pathlab Adjusts Valuation Amid Strong Sales Growth and Debt Concerns",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/aspira-pathlab-diagnostics-stock-downgraded-to-sell-amid-technical-shift-1692681",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/4/AspiraPathlabDi_mojoScore_882208.png",
        "date": "2025-04-03 08:13:08",
        "description": "Aspira Pathlab & Diagnostics has recently experienced an evaluation adjustment reflecting changes in its financial metrics and market position. The company reported significant growth in net sales and profit after tax, although concerns remain regarding its long-term fundamental strength and ability to manage debt."
      },
      {
        "title": "Aspira Pathlab Faces Intense Selling Pressure Amid Significant Stock Decline",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/aspira-pathlab-faces-selling-pressure-with-4-99-decline-total-loss-of-24-36-over-six-days-1671798",
        "imagepath": "",
        "date": "2025-04-02 09:35:35",
        "description": "Aspira Pathlab & Diagnostics Ltd is currently facing significant selling pressure, with the stock showing only sellers today. The company has experienced a notable decline, with its stock price down 4.99% in a single day, contrasting sharply with the Sensex, which gained 0.54% during the same period. Over the past week, Aspira Pathlab has lost 18.53%, while the Sensex fell by just 1.11%. \n\nThis marks the sixth consecutive day of losses for Aspira Pathlab, resulting in a total decline of 24.36% over this timeframe. The stock opened at Rs 76.93 today, reflecting a gap down of 4.99%, and reached an intraday low of Rs 76.93, indicating a lack of upward movement throughout the trading session. \n\nDespite a strong performance over the past year, where the stock surged by 133.97% compared to the Sensex's 3.42%, recent trends suggest a shift in market sentiment. The stock's performance relative to its moving average..."
      },
      {
        "title": "Aspira Pathlab Faces Intense Selling Pressure Amidst Consecutive Losses and Market Concerns",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/aspira-pathlab-diagnostics-ltd-faces-9-74-decline-amid-significant-selling-pressure-today-1657988",
        "imagepath": "",
        "date": "2025-04-01 10:15:39",
        "description": "Aspira Pathlab & Diagnostics Ltd is currently facing significant selling pressure, with the stock showing only sellers today. The company has experienced consecutive days of losses, with a notable decline of 9.74% in just one day, starkly contrasting with the Sensex's modest drop of 0.70%. Over the past week, Aspira's performance has worsened, down 16.41%, while the Sensex has remained relatively stable with a slight increase of 0.20%.\n\nDespite a strong performance in the longer term, including a remarkable 161.19% increase over the past year, the recent trend raises concerns. The stock's year-to-date performance stands at 36.08%, outperforming the Sensex, which has declined by 1.38%. However, the current selling pressure may be attributed to various factors, including market sentiment and potential profit-taking after a strong rally.\n\nIn terms of price summary, Aspira Pathlab is currently underperforming i..."
      },
      {
        "title": "Aspira Pathlab & Diagnostics Adjusts Valuation Amidst Competitive Healthcare Landscape",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/aspira-pathlabs-valuation-grade-changes-from-expensive-to-fair-amid-stock-price-decline-1656118",
        "imagepath": "",
        "date": "2025-04-01 08:00:44",
        "description": "Aspira Pathlab & Diagnostics has recently undergone a valuation adjustment, reflecting a shift in its financial standing within the Hospital & Healthcare Services industry. The company's current price stands at 85.23, down from a previous close of 89.71, with a notable 52-week high of 106.78 and a low of 25.00. \n\nKey financial metrics reveal a PE ratio of 87.73 and an EV to EBITDA of 36.89, indicating a complex valuation landscape. The PEG ratio is recorded at 0.65, suggesting a different growth perspective compared to its peers. Aspira's return metrics show a 1-year return of 174.94%, significantly outperforming the Sensex's 5.11% over the same period. \n\nIn comparison to its peers, Aspira's valuation metrics present a mixed picture. For instance, while some competitors exhibit lower PE ratios, others are categorized differently based on their financial health and market positioning. This evaluation revisio..."
      },
      {
        "title": "Aspira Pathlab Faces Intense Selling Pressure Amidst Significant Price Declines",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/aspira-pathlab-diagnostics-ltd-faces-4-99-decline-amid-significant-selling-pressure-today-1638633",
        "imagepath": "",
        "date": "2025-03-28 09:35:44",
        "description": "Aspira Pathlab & Diagnostics Ltd is currently facing significant selling pressure, with today's trading session showing only sellers. The stock has experienced a notable decline of 4.99%, sharply contrasting with the Sensex's modest drop of 0.20%. This marks the fourth consecutive day of losses for Aspira, accumulating a total decline of 16.19% over this period.\n\nIn terms of performance metrics, Aspira's one-week performance is down 12.01%, while the Sensex has gained 0.71%. Despite a strong year-to-date performance of 43.24%, the recent trend indicates a shift in market sentiment. The stock opened today at Rs 85.23, hitting an intraday low of the same price, and has not shown any range of movement since.\n\nWhile Aspira has outperformed the Sensex over longer periods, including a remarkable 174.94% increase over the past year, the current selling pressure may be attributed to various factors, including marke..."
      },
      {
        "title": "Aspira Pathlab Faces Intense Selling Pressure Amid Significant Price Declines",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/aspira-pathlab-faces-significant-selling-pressure-with-5-decline-amidst-ongoing-losses-1621672",
        "imagepath": "",
        "date": "2025-03-27 09:40:37",
        "description": "Aspira Pathlab & Diagnostics Ltd is currently facing significant selling pressure, with the stock showing only sellers today. The stock has experienced a consecutive decline over the past three days, resulting in a total loss of 11.79%. Today, it opened with a gap down of 5%, reaching an intraday low of Rs 89.71. \n\nIn terms of performance, Aspira Pathlab has underperformed the broader market, with a one-day decline of 5.00% compared to the Sensex's modest gain of 0.19%. Over the past week, the stock has decreased by 2.75%, while the Sensex has risen by 1.42%. Despite a strong performance over the past month, where the stock gained 20.05%, the recent trend indicates a shift in market sentiment.\n\nThe stock's performance relative to the Sensex reveals a stark contrast, particularly over the last three months, where Aspira Pathlab surged by 51.79% against the Sensex's decline of 1.61%. However, the current sell..."
      },
      {
        "title": "Aspira Pathlab Faces Intense Selling Pressure Amid Recent Price Declines",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/aspira-pathlab-faces-selling-pressure-declines-4-99-amidst-consecutive-losses-of-7-15-1600074",
        "imagepath": "",
        "date": "2025-03-26 09:35:46",
        "description": "Aspira Pathlab & Diagnostics Ltd is currently facing significant selling pressure, with the stock showing only sellers today. The company has experienced consecutive losses over the past two days, with a total decline of 7.15%. Today, the stock opened with a gap down of 3.41% and reached an intraday low of Rs 94.43, reflecting a decrease of 4.99%. \n\nIn terms of performance relative to the Sensex, Aspira Pathlab has underperformed significantly today, with the Sensex declining only 0.04%. However, over the past week, the stock had shown a positive trend, gaining 7.31%, while the Sensex rose by 3.36%. Over the past month, Aspira Pathlab has delivered a remarkable 32.66% increase compared to the Sensex's 4.53%. \n\nDespite its recent strong performance over longer periods, including a 172.13% increase over the past year, the current selling pressure may be attributed to various market dynamics, including profit-..."
      },
      {
        "title": "Aspira Pathlab Faces Significant Selling Pressure Amid Notable Price Decline",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/aspira-pathlab-faces-selling-pressure-stock-declines-5-amid-market-volatility-and-losses-1578812",
        "imagepath": "",
        "date": "2025-03-25 10:25:11",
        "description": "Aspira Pathlab & Diagnostics Ltd is currently facing significant selling pressure, with the stock showing only sellers today. The company has experienced a notable decline of 5.00% in its stock price, contrasting sharply with the Sensex, which has gained 0.74%. This marks a reversal after three consecutive days of gains, indicating a shift in market sentiment.\n\nOver the past week, Aspira Pathlab has still managed a positive performance of 9.78%, but the current day's losses highlight a concerning trend. The stock has demonstrated impressive growth over the past month, up 35.74%, and an extraordinary 209.18% increase over the past year. However, today’s performance underperformed its sector by 4.57%, suggesting that external factors may be influencing the selling pressure.\n\nThe stock opened with a 5% gain, reaching an intraday high of Rs. 106.78, but quickly fell to a low of Rs. 96.62, showcasing high volati..."
      }
    ],
    "total": 4055,
    "sid": "1002885",
    "stock_news_url": "https://sandbox-www.marketsmojo.com/news/aspira-pathlab-diagnostics-1002885"
  },
  "announcements": [
    {
      "caption": "Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
      "datetime": "09-Apr-2025",
      "details": "Compliance Certificate in accordance with regulation 74(5) of the SEBI (Depositories and Participants) Regulations 2018 for the quarter ended March 31 2025",
      "source": "BSE"
    },
    {
      "caption": "Intimation Under Regulation 30 Of The SEBI (LODR) Regulations 2015",
      "datetime": "08-Apr-2025",
      "details": "Announcement as per regulation 30 of the SEBI (LODR) Regulations 2015",
      "source": "BSE"
    },
    {
      "caption": "Closure of Trading Window",
      "datetime": "26-Mar-2025",
      "details": "Intimation of Closure of Trading Window for the quarter and year ended March 31 2025",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "No <strong>Dividend</strong> history available",
      "data": []
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Aspira Pathlab Faces Intense Selling Pressure Amid Significant Price Declines

2025-04-03 09:35:24

Aspira Pathlab & Diagnostics Ltd is currently facing significant selling pressure, with the stock showing only sellers today. The stock has experienced a notable decline of 4.99% in just one day, significantly underperforming the Sensex, which fell by only 0.58%. Over the past week, Aspira has seen a staggering loss of 18.53%, while the Sensex declined by 1.85%. This trend of consecutive losses extends to seven days, during which Aspira has plummeted by 28.13%. The stock opened today at Rs 73.09, reflecting a gap down, and reached an intraday low of the same price, indicating a lack of upward movement. In terms of performance metrics, Aspira's one-month performance shows a decline of 4.64%, contrasting sharply with the Sensex's gain of 4.22%. Despite a strong one-year performance of 115.86% compared to the Sensex's 3.11%, the recent downturn raises questions about potential contributing factors to the s...

Read More

Aspira Pathlab Adjusts Valuation Amid Strong Sales Growth and Debt Concerns

2025-04-03 08:13:08

Aspira Pathlab & Diagnostics has recently experienced an evaluation adjustment reflecting changes in its financial metrics and market position. The company reported significant growth in net sales and profit after tax, although concerns remain regarding its long-term fundamental strength and ability to manage debt.

Read More

Aspira Pathlab Faces Intense Selling Pressure Amid Significant Stock Decline

2025-04-02 09:35:35

Aspira Pathlab & Diagnostics Ltd is currently facing significant selling pressure, with the stock showing only sellers today. The company has experienced a notable decline, with its stock price down 4.99% in a single day, contrasting sharply with the Sensex, which gained 0.54% during the same period. Over the past week, Aspira Pathlab has lost 18.53%, while the Sensex fell by just 1.11%. This marks the sixth consecutive day of losses for Aspira Pathlab, resulting in a total decline of 24.36% over this timeframe. The stock opened at Rs 76.93 today, reflecting a gap down of 4.99%, and reached an intraday low of Rs 76.93, indicating a lack of upward movement throughout the trading session. Despite a strong performance over the past year, where the stock surged by 133.97% compared to the Sensex's 3.42%, recent trends suggest a shift in market sentiment. The stock's performance relative to its moving average...

Read More

Aspira Pathlab Faces Intense Selling Pressure Amidst Consecutive Losses and Market Concerns

2025-04-01 10:15:39

Aspira Pathlab & Diagnostics Ltd is currently facing significant selling pressure, with the stock showing only sellers today. The company has experienced consecutive days of losses, with a notable decline of 9.74% in just one day, starkly contrasting with the Sensex's modest drop of 0.70%. Over the past week, Aspira's performance has worsened, down 16.41%, while the Sensex has remained relatively stable with a slight increase of 0.20%. Despite a strong performance in the longer term, including a remarkable 161.19% increase over the past year, the recent trend raises concerns. The stock's year-to-date performance stands at 36.08%, outperforming the Sensex, which has declined by 1.38%. However, the current selling pressure may be attributed to various factors, including market sentiment and potential profit-taking after a strong rally. In terms of price summary, Aspira Pathlab is currently underperforming i...

Read More

Aspira Pathlab & Diagnostics Adjusts Valuation Amidst Competitive Healthcare Landscape

2025-04-01 08:00:44

Aspira Pathlab & Diagnostics has recently undergone a valuation adjustment, reflecting a shift in its financial standing within the Hospital & Healthcare Services industry. The company's current price stands at 85.23, down from a previous close of 89.71, with a notable 52-week high of 106.78 and a low of 25.00. Key financial metrics reveal a PE ratio of 87.73 and an EV to EBITDA of 36.89, indicating a complex valuation landscape. The PEG ratio is recorded at 0.65, suggesting a different growth perspective compared to its peers. Aspira's return metrics show a 1-year return of 174.94%, significantly outperforming the Sensex's 5.11% over the same period. In comparison to its peers, Aspira's valuation metrics present a mixed picture. For instance, while some competitors exhibit lower PE ratios, others are categorized differently based on their financial health and market positioning. This evaluation revisio...

Read More

Aspira Pathlab Faces Intense Selling Pressure Amidst Significant Price Declines

2025-03-28 09:35:44

Aspira Pathlab & Diagnostics Ltd is currently facing significant selling pressure, with today's trading session showing only sellers. The stock has experienced a notable decline of 4.99%, sharply contrasting with the Sensex's modest drop of 0.20%. This marks the fourth consecutive day of losses for Aspira, accumulating a total decline of 16.19% over this period. In terms of performance metrics, Aspira's one-week performance is down 12.01%, while the Sensex has gained 0.71%. Despite a strong year-to-date performance of 43.24%, the recent trend indicates a shift in market sentiment. The stock opened today at Rs 85.23, hitting an intraday low of the same price, and has not shown any range of movement since. While Aspira has outperformed the Sensex over longer periods, including a remarkable 174.94% increase over the past year, the current selling pressure may be attributed to various factors, including marke...

Read More

Aspira Pathlab Faces Intense Selling Pressure Amid Significant Price Declines

2025-03-27 09:40:37

Aspira Pathlab & Diagnostics Ltd is currently facing significant selling pressure, with the stock showing only sellers today. The stock has experienced a consecutive decline over the past three days, resulting in a total loss of 11.79%. Today, it opened with a gap down of 5%, reaching an intraday low of Rs 89.71. In terms of performance, Aspira Pathlab has underperformed the broader market, with a one-day decline of 5.00% compared to the Sensex's modest gain of 0.19%. Over the past week, the stock has decreased by 2.75%, while the Sensex has risen by 1.42%. Despite a strong performance over the past month, where the stock gained 20.05%, the recent trend indicates a shift in market sentiment. The stock's performance relative to the Sensex reveals a stark contrast, particularly over the last three months, where Aspira Pathlab surged by 51.79% against the Sensex's decline of 1.61%. However, the current sell...

Read More

Aspira Pathlab Faces Intense Selling Pressure Amid Recent Price Declines

2025-03-26 09:35:46

Aspira Pathlab & Diagnostics Ltd is currently facing significant selling pressure, with the stock showing only sellers today. The company has experienced consecutive losses over the past two days, with a total decline of 7.15%. Today, the stock opened with a gap down of 3.41% and reached an intraday low of Rs 94.43, reflecting a decrease of 4.99%. In terms of performance relative to the Sensex, Aspira Pathlab has underperformed significantly today, with the Sensex declining only 0.04%. However, over the past week, the stock had shown a positive trend, gaining 7.31%, while the Sensex rose by 3.36%. Over the past month, Aspira Pathlab has delivered a remarkable 32.66% increase compared to the Sensex's 4.53%. Despite its recent strong performance over longer periods, including a 172.13% increase over the past year, the current selling pressure may be attributed to various market dynamics, including profit-...

Read More

Aspira Pathlab Faces Significant Selling Pressure Amid Notable Price Decline

2025-03-25 10:25:11

Aspira Pathlab & Diagnostics Ltd is currently facing significant selling pressure, with the stock showing only sellers today. The company has experienced a notable decline of 5.00% in its stock price, contrasting sharply with the Sensex, which has gained 0.74%. This marks a reversal after three consecutive days of gains, indicating a shift in market sentiment. Over the past week, Aspira Pathlab has still managed a positive performance of 9.78%, but the current day's losses highlight a concerning trend. The stock has demonstrated impressive growth over the past month, up 35.74%, and an extraordinary 209.18% increase over the past year. However, today’s performance underperformed its sector by 4.57%, suggesting that external factors may be influencing the selling pressure. The stock opened with a 5% gain, reaching an intraday high of Rs. 106.78, but quickly fell to a low of Rs. 96.62, showcasing high volati...

Read More

View All News